Pfizer Breakthrough Growth Initiative
Description
Pfizer Breakthrough Growth Initiative provide funding to biotechnology companies.
Investor Profile
Pfizer Breakthrough Growth Initiative has made 3 investments, with 0 in the past 12 months and 67% as lead.
Stage Focus
- Series A (33%)
- Post Ipo Equity (33%)
- Series B (33%)
Country Focus
- United States (33%)
- Canada (33%)
- Belgium (33%)
Industry Focus
- Biotechnology
- Therapeutics
- Health Care
- Pharmaceutical
- Biopharma
- Clinical Trials
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.